Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAPGEF4 | Q8WZA2 | 2/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | BRAF | P15056 | 4/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | SYK | P43405 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | APP | P05067 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7001007 | 0.86 | RAPGEF4 (0.53) | RAPGEF4ACHEMAPTGAAALDH1A1 | |
| SCHEMBL5608725 | 0.85 | NPSR1 (0.59) | RAPGEF4CYP3A4MAPTGAAMEN1 | |
| SCHEMBL11536805 | 0.83 | RAPGEF4 (0.54) | RAPGEF4CYP3A4TSHRACHEBRAF | |
| SCHEMBL3234606 | 0.82 | RAPGEF4 (0.61) | RAPGEF4CYP3A4TSHRBRAFHDAC6 | |
| Formaldehyde SCHEMBL9774242 | 0.82 | CXCR2 (0.58) | RAPGEF4CYP3A4TSHRACHEBRAF | |
| SCHEMBL11563580 | 0.80 | RAPGEF4 (0.55) | RAPGEF4CYP3A4TSHRACHEMAPT | |
| SCHEMBL11536888 | 0.80 | RAPGEF4 (0.54) | RAPGEF4CYP3A4TSHRACHEBRAF | |
| SCHEMBL429859 | 0.80 | GAA (0.62) | RAPGEF4MAPTGAAMEN1KMT2A | |
| SCHEMBL29473561 | 0.80 | GAA (0.62) | RAPGEF4MAPTGAAMEN1KMT2A | |
| SCHEMBL7003942 | 0.80 | RAPGEF4 (0.64) | RAPGEF4MAPTGAAALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6919357-B2 | α adrenergic agents | MOLECULAR DESIGN INTERNATIONAL INC. (US) | 2005-07-19 | — | — | US | disclosed |
| EP-1418907-A4 | NOVEL ALPHA ADRENERGIC AGENTS | MOLECULAR DESIGN INTERNAT INC (US) | 2004-10-20 | — | — | EP | disclosed |
| EP-1418907-A1 | NOVEL ALPHA ADRENERGIC AGENTS | Molecular Design International Inc. (US) | 2004-05-19 | — | — | EP | disclosed |
| US-20030092741-A1 | Novel alpha adrenergic agents | MOLECTULAR DESIGN INTERNATIONAL INC. | 2003-05-15 | — | — | US | disclosed |
| WO-2003013515-A1 | NOVEL ALPHA ADRENERGIC AGENTS | MOLECTULAR DESIGN INTERNATIONAL INC. (US) | 2003-02-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030092741-A1 | Novel alpha adrenergic agents | ADRA1D, ADRB1, ADRA1B | RAPGEF4 2602/4885CYP3A4 1191/4885TSHR 3454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.